The study identified epimorphin 5 (EPM5) as a direct target of miR-200c, and its high expression was enriched in consensus molecular subtype (CMS) 4, a poor-prognosis CRC subtype. The gene discussed is PRICKLE2; the disease is colorectal carcinoma.